These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17112623)

  • 21. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
    He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
    J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Assessment of serum GPC3 as a tumor marker for hepatocellular carcinoma and malignant melanoma].
    Komori H; Beppu T; Baba H; Nakatsura T; Nishimura Y
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():833-6. PubMed ID: 20960882
    [No Abstract]   [Full Text] [Related]  

  • 23. [PIVKA-II as a serological marker of hepatocellular carcinoma].
    Jeong SH
    Korean J Hepatol; 2006 Sep; 12(3):315-7. PubMed ID: 16998285
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
    Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Jul; 50(1):325. PubMed ID: 19492428
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence.
    Singhal A; Jayaraman M; Dhanasekaran DN; Kohli V
    Crit Rev Oncol Hematol; 2012 May; 82(2):116-40. PubMed ID: 21680198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry.
    Xue R; Lin Z; Deng C; Dong L; Liu T; Wang J; Shen X
    Rapid Commun Mass Spectrom; 2008 Oct; 22(19):3061-8. PubMed ID: 18767022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas.
    Riener MO; Stenner F; Liewen H; Hellerbrand C; Bahra M; Kristiansen G
    Hepatology; 2009 Jul; 50(1):326. PubMed ID: 19496179
    [No Abstract]   [Full Text] [Related]  

  • 30. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
    Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma.
    Tangkijvanich P; Hourpai N; Rattanatanyong P; Wisedopas N; Mahachai V; Mutirangura A
    Clin Chim Acta; 2007 Apr; 379(1-2):127-33. PubMed ID: 17303099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
    Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
    Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surgical therapy of hepatic fibrolamellar carcinoma].
    Meriggi F; Forni E
    Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
    Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma.
    Wang K; Xu X; Nie Y; Dai L; Wang P; Zhang J
    Cancer Lett; 2009 Aug; 281(2):144-50. PubMed ID: 19304375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
    Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody.
    Tanaka K; Shimada H; Matsuo K; Nagano Y; Endo I; Togo S
    Ann Surg Oncol; 2007 Mar; 14(3):1170-81. PubMed ID: 17195904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological surveillance for hepatocellular carcinoma: time to quit.
    Sherman M
    J Hepatol; 2010 Apr; 52(4):614-5. PubMed ID: 20185193
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnosis of small hepatocellular carcinoma.
    Sherman M
    Hepatology; 2005 Jul; 42(1):14-6. PubMed ID: 15962322
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.